{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:47:29Z","timestamp":1778280449086,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T12:50:28Z","timestamp":1686833428000},"page":"4497-4507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterization of epitopes of human monoclonal antibodies against cytomegalovirus glycoprotein B for neutralization and antibody-dependent phagocytosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Keisuke","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9759-273X","authenticated-orcid":false,"given":"Tomohiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Koshizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Torikai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.003_b0005","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1086\/598506","article-title":"Dried umbilical cords in the retrospective diagnosis of congenital cytomegalovirus infection as a cause of developmental delays","volume":"48","author":"Koyano","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/511981","article-title":"Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations","volume":"195","author":"Ogawa","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0015","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-055896","article-title":"Emerging concepts in congenital cytomegalovirus","volume":"150","author":"Pesch","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.06.003_b0020","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0025","doi-asserted-by":"crossref","unstructured":"Stratton KR, Durch JS, Lawrence RS. Vaccines for the 21st Century. Washington, D.C.: National Academies Press; 2000. doi: 10.17226\/5501.","DOI":"10.17226\/5501"},{"key":"10.1016\/j.vaccine.2023.06.003_b0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"77 (24)","key":"10.1016\/j.vaccine.2023.06.003_b0035","doi-asserted-by":"crossref","first-page":"13301","DOI":"10.1128\/JVI.77.24.13301-13314.2003","article-title":"Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity","author":"Pereira","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0045","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320714","article-title":"Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs","volume":"183","author":"Chatterjee","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004060","article-title":"A neutralizing anti-gH\/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection","volume":"10","author":"Auerbach","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.06.003_b0055","article-title":"Crystal structure of the human cytomegalovirus glycoprotein B","volume":"11","author":"Burke","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.06.003_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9176","article-title":"Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody","volume":"6","author":"Chandramouli","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.06.003_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002172","article-title":"B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies","volume":"7","author":"P\u00f6tzsch","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.06.003_b0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/jvi.67.2.703-710.1993","article-title":"Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58\/116 (gB), as determined with human monoclonal antibodies","volume":"67","author":"Ohlin","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/viro.1996.0040","article-title":"Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures","volume":"216","author":"Schoppel","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.06.003_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004377","article-title":"Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody","volume":"10","author":"Spindler","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.06.003_b0085","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1128\/JVI.00434-13","article-title":"Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus","volume":"87","author":"Spindler","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/JVI.02393-14","article-title":"Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus","volume":"89","author":"Wiegers","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123982","article-title":"A native human monoclonal antibody targeting HCMV gB (AD-2 site I)","volume":"19","author":"McVoy","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.06.003_b0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"Pass","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0105","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.06.003_b0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.003_b0115","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.06.003_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/v10120704","article-title":"Pathogen at the gates: Human cytomegalovirus entry and cell tropism","volume":"10","author":"Nguyen","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.06.003_b0125","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/jgv.0.000882","article-title":"The pentameric complex of human cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development","volume":"98","author":"Gerna","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154461","article-title":"Influenza-specific antibody-dependent phagocytosis","volume":"11","author":"Ana-Sosa-Batiz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.06.003_b0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imr.12339","article-title":"The role of Fc receptors in HIV prevention and therapy","volume":"268","author":"Boesch","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2023.06.003_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109167","article-title":"Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells","volume":"35","author":"Rossignol","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2023.06.003_b0145","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41591-018-0161-0","article-title":"Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV","volume":"24","author":"Ackerman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.06.003_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15711","article-title":"Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge","volume":"8","author":"Bradley","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.06.003_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease","volume":"10","author":"van Erp","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/v13061037","article-title":"Requirement of Fc-Fc gamma receptor interaction for antibody-based protection against emerging virus infections","volume":"13","author":"Keeler","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.06.003_b0165","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2023.06.003_b0170","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2023.06.003_b0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2020.07.009","article-title":"Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection","volume":"548","author":"Goodwin","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.06.003_b0180","doi-asserted-by":"crossref","first-page":"73654","DOI":"10.18632\/oncotarget.18359","article-title":"Active evolution of memory B-cells specific to viral gH\/gL\/ pUL128\/130\/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2023.06.003_b0185","unstructured":"Torikai M, Mori H, Nishimura T, Matsumoto M, Shimizu H, Koube A, et al. Modified CMV gB protein and CMV vaccine including same. WO\/2020\/085457, 2020. https:\/\/patentscope2.wipo.int\/search\/en\/detail.jsf?docId=WO2020085457 or https:\/\/patentscope2.wipo.int\/search\/en\/search.jsf, and then search with the term \u201cWO2020085457\u201d."},{"key":"10.1016\/j.vaccine.2023.06.003_b0190","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1016\/j.vaccine.2018.08.054","article-title":"Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates","volume":"36","author":"Kobayashi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.003_b0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/rmv.438","article-title":"Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains","volume":"14","author":"Pignatelli","year":"2004","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3611","article-title":"Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB\/MF59 vaccine in humans","volume":"12","author":"Jenks","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2023.06.003_b0205","article-title":"Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion","volume":"7","author":"Liu","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2023.06.003_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007452","article-title":"Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate","volume":"14","author":"Si","year":"2018","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2023.06.003_b0215","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1016\/S0021-9258(17)46181-3","article-title":"The structure of protein-protein recognition sites","volume":"265","author":"Janin","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2023.06.003_b0220","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2013.04.078","article-title":"Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta","volume":"31","author":"Hashimoto","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.003_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158206","article-title":"Analysis and fine specificity of the HCMV-specific cell-free and cell-associated antibody-dependent cellular phagocytosis (ADCP) responses in lung transplant recipients","volume":"22","author":"Eberhard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.06.003_b0230","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156827","article-title":"Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection","volume":"132","author":"Semmes","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.06.003_b0235","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/infdis\/jiz089","article-title":"Original antigenic sin shapes the immunological repertoire evoked by human cytomegalovirus glycoprotein B\/MF59 vaccine in seropositive recipients","volume":"220","author":"Baraniak","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.003_b0240","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-virology-092917-043236","article-title":"Congenital viral infection: Traversing the uterine-placental interface","volume":"5","author":"Pereira","year":"2018","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.vaccine.2023.06.003_b0250","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gki385","article-title":"GlyProt: in silico glycosylation of proteins","volume":"33","author":"Bohne-Lang","year":"2005","journal-title":"Nucleic Acids Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300659X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300659X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:55Z","timestamp":1759404535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2300659X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X2300659X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of epitopes of human monoclonal antibodies against cytomegalovirus glycoprotein B for neutralization and antibody-dependent phagocytosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}